Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)ethanol
2. Atarax
3. Durrax
4. Hydroxyzine
5. Hydroxyzine Dihydrochloride
6. Hydroxyzine Pamoate
7. Orgatrax
8. Pamoate, Hydroxyzine
9. Vistaril
1. Hydroxyzine Hcl
2. 1244-76-4
3. Hydroxyzine Monohydrochloride
4. Ca67jf5q4w
5. Mls000028602
6. Smr000058737
7. 2-(2-(4-((4-chlorophenyl)phenylmethyl)piperazin-1-yl)ethoxy)ethanol Hydrochloride
8. 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol;hydrochloride
9. 2-[2-[4-[(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]ethanol Hydrochloride
10. Einecs 214-989-3
11. Unii-ca67jf5q4w
12. Hydroxyzin Hydrochloride
13. Opera_id_1515
14. 1-(p-chlorobenzhydryl)-4-(2-(2-hydroxyethoxy)ethyl)diethylenediamine Hydrochloride
15. Dsstox_cid_27530
16. Dsstox_rid_82400
17. Dsstox_gsid_47530
18. Schembl41448
19. Mls002222192
20. Chembl1201007
21. Dtxsid5047530
22. Tox21_302563
23. Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, Monohydrochloride
24. Ethanol, 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)-, Hydrochloride
25. Ethanol, 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)-, Monohydrochloride
26. Ncgc00180974-01
27. Ncgc00256629-01
28. 14729-22-7
29. Cas-1244-76-4
30. Q27275377
31. 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol;hydron;chloride
32. 2-[2-[4-[(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]ethanolhydrochloride
33. Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, Hydrochloride (1:1)
34. Ethanol, 2-(2-(4-(p-chloro-.alpha.-phenylbenzyl)-1-piperazinyl)ethoxy)-, Monohydrochloride
| Molecular Weight | 411.4 g/mol |
|---|---|
| Molecular Formula | C21H28Cl2N2O2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 8 |
| Exact Mass | 410.1527835 g/mol |
| Monoisotopic Mass | 410.1527835 g/mol |
| Topological Polar Surface Area | 35.9 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 376 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antipruritics
Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
API SUPPLIERS
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-03-12
Pay. Date : 2023-12-01
DMF Number : 35249
Submission : 2023-12-05
Status : Active
Type : II
NDC Package Code : 65319-1096
Start Marketing Date : 2019-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Jai Radhe Sales is your partner for all your sourcing needs.
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
Harika Drugs has been providing a qualitative range of Bulk Drugs/ APIs since 1993.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-11-18
Pay. Date : 2016-10-24
DMF Number : 19596
Submission : 2006-07-12
Status : Active
Type : II
Certificate Number : R1-CEP 2015-186 - Rev 00
Issue Date : 2021-07-12
Type : Chemical
Substance Number : 916
Status : Valid
Date of Issue : 2022-10-21
Valid Till : 2025-09-11
Written Confirmation Number : WC-0451
Address of the Firm :
NDC Package Code : 66022-0104
Start Marketing Date : 1982-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3623
Submission : 1979-08-27
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13852
Submission : 1998-11-19
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3037
Submission : 1977-10-13
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - 25MG/ML **Fed...DOSAGE - INJECTABLE;INJECTION - 25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 11111
DOSAGE - INJECTABLE;INJECTION - 50MG/ML **Fed...DOSAGE - INJECTABLE;INJECTION - 50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 11111
DOSAGE - SYRUP;ORAL - 10MG/5ML
USFDA APPLICATION NUMBER - 87294
DOSAGE - INJECTABLE;INJECTION - 25MG/ML
USFDA APPLICATION NUMBER - 87408
DOSAGE - INJECTABLE;INJECTION - 50MG/ML
USFDA APPLICATION NUMBER - 87408
DOSAGE - TABLET;ORAL - 25MG
USFDA APPLICATION NUMBER - 88618
DOSAGE - TABLET;ORAL - 50MG
USFDA APPLICATION NUMBER - 88619
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
92
PharmaCompass offers a list of Hydroxyzine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hydroxyzine Hydrochloride manufacturer or Hydroxyzine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hydroxyzine Hydrochloride manufacturer or Hydroxyzine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Hydroxyzine Hydrochloride API Price utilized in the formulation of products. Hydroxyzine Hydrochloride API Price is not always fixed or binding as the Hydroxyzine Hydrochloride Price is obtained through a variety of data sources. The Hydroxyzine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Hydroxyzine Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydroxyzine Dihydrochloride, including repackagers and relabelers. The FDA regulates Hydroxyzine Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydroxyzine Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hydroxyzine Dihydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hydroxyzine Dihydrochloride supplier is an individual or a company that provides Hydroxyzine Dihydrochloride active pharmaceutical ingredient (API) or Hydroxyzine Dihydrochloride finished formulations upon request. The Hydroxyzine Dihydrochloride suppliers may include Hydroxyzine Dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Hydroxyzine Dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hydroxyzine Dihydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Hydroxyzine Dihydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Hydroxyzine Dihydrochloride DMFs exist exist since differing nations have different regulations, such as Hydroxyzine Dihydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Hydroxyzine Dihydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Hydroxyzine Dihydrochloride USDMF includes data on Hydroxyzine Dihydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Hydroxyzine Dihydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Hydroxyzine Dihydrochloride suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Hydroxyzine Dihydrochloride Drug Master File in Korea (Hydroxyzine Dihydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Hydroxyzine Dihydrochloride. The MFDS reviews the Hydroxyzine Dihydrochloride KDMF as part of the drug registration process and uses the information provided in the Hydroxyzine Dihydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Hydroxyzine Dihydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Hydroxyzine Dihydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Hydroxyzine Dihydrochloride suppliers with KDMF on PharmaCompass.
A Hydroxyzine Dihydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Hydroxyzine Dihydrochloride Certificate of Suitability (COS). The purpose of a Hydroxyzine Dihydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Hydroxyzine Dihydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Hydroxyzine Dihydrochloride to their clients by showing that a Hydroxyzine Dihydrochloride CEP has been issued for it. The manufacturer submits a Hydroxyzine Dihydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Hydroxyzine Dihydrochloride CEP holder for the record. Additionally, the data presented in the Hydroxyzine Dihydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Hydroxyzine Dihydrochloride DMF.
A Hydroxyzine Dihydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Hydroxyzine Dihydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Hydroxyzine Dihydrochloride suppliers with CEP (COS) on PharmaCompass.
A Hydroxyzine Dihydrochloride written confirmation (Hydroxyzine Dihydrochloride WC) is an official document issued by a regulatory agency to a Hydroxyzine Dihydrochloride manufacturer, verifying that the manufacturing facility of a Hydroxyzine Dihydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Hydroxyzine Dihydrochloride APIs or Hydroxyzine Dihydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Hydroxyzine Dihydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Hydroxyzine Dihydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hydroxyzine Dihydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Hydroxyzine Dihydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Hydroxyzine Dihydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Hydroxyzine Dihydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hydroxyzine Dihydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Hydroxyzine Dihydrochloride suppliers with NDC on PharmaCompass.
Hydroxyzine Dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hydroxyzine Dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hydroxyzine Dihydrochloride GMP manufacturer or Hydroxyzine Dihydrochloride GMP API supplier for your needs.
A Hydroxyzine Dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Hydroxyzine Dihydrochloride's compliance with Hydroxyzine Dihydrochloride specifications and serves as a tool for batch-level quality control.
Hydroxyzine Dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Hydroxyzine Dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hydroxyzine Dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Hydroxyzine Dihydrochloride EP), Hydroxyzine Dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hydroxyzine Dihydrochloride USP).
